Thus, compared to the same period last year, there is an increase in the number of applications from domestic developers in this area.
“For the period from January to August 2022, domestic developers filed 478 applications for an invention in the field of pharmaceuticals.
The positive dynamics in the volume of applications from domestic developers increased by 12% compared to 2021,” the department noted.
In addition, as experts explained, as of August 2022, inventors from universities and pharmaceutical manufacturers are the most active.
Also, as previously reported in the department, since February, the number of applications for antibacterial drugs, including broad-spectrum drugs and those aimed at treating tuberculosis, has tripled.
In July, Rospatent named the main areas of inventions by Russian scientists.